It's here. The cholesterol-fighter Liptor, the biggest hit in the history of the pharmaceutical industry, is now widely available in generic form.
The Pfizer drug finally lost its U.S. patent protection at the end of November, opening the door for cheaper substitutes (atorvastatin, generically) and ending the monopoly for one of the most profitable brand-name products of any kind.